• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Immunic Enrolls First Patient in Ph 2 Trial of Vidofludimus Calcium

    PR NEWSWIRE

    Immunic Receives Notice of Allowance for Patent Protecting the Treatment of Relapsing Multiple Sclerosis with Vidofludimus

    PR NEWSWIRE

    Immunic Presents Data From Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium

    PR NEWSWIRE

    Immunic Completes Enrollment of Phase 2 CALLIPER Trial of Vidofludimus Calcium

    PR NEWSWIRE

    Immunic touts positive data in maintenance phase of failed PhII trial, pulls back asset

    ENDPTS

    Immunic Reports Positive Data from PII CALDOSE-1 Trial of Vidofludimus Calcium

    PR NEWSWIRE

    Immunic Presents Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium

    PR NEWSWIRE

    Immunic Reports New Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium

    PRNEWSWIRE

    Immunic regains some momentum with multiple sclerosis update

    FIERCEBIOTECH

    Immunic shares cut in half as biotech dumps ulcerative colitis after PhII fail

    ENDPTS

    Immunic Reports Top-Line Data from PII CALDOSE-1 Trial of Vidofludimus Calcium

    PRNEWSWIRE

    Immunic Begins Enrollment in Phase 3 Program of vidofludimus calcium in MS

    PRNEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.